Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
| Autor: | Krop, I.E. *, Lin, N.U., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D., Samant, M., Welslau, M., Diéras, V. |
|---|---|
| Zdroj: | In Annals of Oncology January 2015 26(1):113-119 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|